Slowing your dose escalation, switching to a different GLP-1 formulation, or adjusting nutritional intake may resolve mood changes without discontinuing treatment
PubMed CrossRef Callaghan JT, Bergstrom RF, Ptak LR, et al
In its lawsuit, the Outsourcing Facility Association (OFA) claims that the agency is dismissing evidence that the shortage persists and that its decision will deprive patients of a vital treatment. Hims & Hers (HIMS) made a killing last year selling an off-brand version of Ozempic, but with the drugs shortage now declared over by the FDA, the company will soon have to halt sales of its cheaper alternative
Led by our expert nurse practitioners, this approach prioritises your comfort, health, and long-term success
Medical professionals follow evidence-based protocols, and without published data demonstrating safety, responsible providers decline to prescribe both drugs at once
However, as of mid-2025, retatrutide has not received regulatory approval in the UK or elsewhere